Chennai

Accenture is a global management consulting, technology services and outsourcing company. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments.

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.

Dell Services is a global provider of innovative solutions and capabilities to clients worldwide. Dell has deep industry expertise and a portfolio of interrelated consulting, business processes, application, and infrastructure services, necessary to create innovative solutions that achieve and sustain measurable results. Dell Inc acquired Perot Systems in the month of October 2009, resulting in the Dell Services organization.

?

Shield Healthcare is today a recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery.

The New National Pharmaceutical Policy would soon be placed for consent before the Cabinet Ministers said Mr M K Azhagiri, Indian Minister of Chemicals & Fertilizers, at the conference on “Intellectual Property Rights: Challenges and Way Forward for the Pharmaceutical Industry”, organized by Confederation of Indian Industry (CII) held in Chennai (India) on December 15, 2010.

Inga Laboratories P. Ltd., a research-based pharmaceutical corporation, was established in 1974. The company’s activities are focused to the development, manufacture and marketing of pharmaceutical formulations at affordable prices.
Inga Laboratories P. Ltd. manufactures galenical forms such as tablets, capsules, liquid orals, injectables and beta lactum formulations in compliance with the latest current Good Manufacturing Practices.